Lexaria Bioscience Corp. LEXX

$ 9.04 11.6%

Quarterly report 2026-Q3
added 07-13-2026

Country	Canada
IPO year	-
Industry	-
Stock Exchange	NASDAQ GLOBAL

Shares	19.6 M
Market Cap^[1]	$ 177 M
EBITDA (LTM)	$ -6.78 M
P/E (LTM)	-2.8
P/S (LTM)	146.02
EPS (LTM)	-1.88

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.